Reported results
- Net revenue was $66 thousand for the three months ended September 30, 2026, compared to $42 thousand for the three months ended September 30, 2025.
- R&D expenses were $3,077 thousand for the three months ended September 30, 2026, compared to $2,700 thousand for the three months ended September 30, 2025.
- Sales and marketing expenses were $157 thousand for the three months ended September 30, 2026, compared to $405 thousand for the three months ended September 30, 2025.
- General and administrative expenses were $2,125 thousand for the three months ended September 30, 2026, compared to $1,999 thousand for the three months ended September 30, 2025.
- Net loss attributable to common stockholders was $5,240 thousand, or $0.50 per basic and diluted share for the three months ended September 30, 2026.
- Cash was approximately $14,570 thousand as of September 30, 2026.
Price and volatility reaction
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-05 (8-K, Item 2.02). Read the original filing on sec.gov.
